Lin D Y, Liaw Y F, Wu C S, Chang-Chien C S, Chen P C, Chen T J
Liver. 1987 Apr;7(2):106-9. doi: 10.1111/j.1600-0676.1987.tb00325.x.
In a consecutive series of 562 patients with pathologically documented hepatocellular carcinoma (HCC), 12 patients (2.1%) were found to have a second primary malignancy elsewhere. Of these, eight were male, four female, with ages ranging from 49 to 76 years (mean 60.7 +/- 9.3 years). The associated cancers included eight cases of gastric cancers, an esophageal cancer, a stump cancer, a case of myelocytic leukemia and a histiocytic lymphoma. Eight cases had both malignancies diagnosed at the same admission. In the other four, HCC were detected after an interval of 4, 10, 12 and 39 months. Two had received previous chemotherapy or radiotherapy. Fifty percent of the 12 patients were hepatitis B surface antigen (HBsAg) positive. Their liver function tests and alpha-fetoprotein levels were consistent with those of patients with HCC alone. The results suggest that the occurrence of HCC concomitant with or arising after another primary malignancy in Taiwan is not rare.
在连续的562例经病理证实的肝细胞癌(HCC)患者中,发现12例(2.1%)在其他部位有第二原发性恶性肿瘤。其中,男性8例,女性4例,年龄在49至76岁之间(平均60.7±9.3岁)。相关癌症包括8例胃癌、1例食管癌、1例残端癌、1例髓细胞白血病和1例组织细胞淋巴瘤。8例患者在同一次入院时被诊断出患有两种恶性肿瘤。在另外4例中,肝细胞癌在间隔4、10、12和39个月后被检测到。2例患者曾接受过化疗或放疗。12例患者中有50%的乙肝表面抗原(HBsAg)呈阳性。他们的肝功能检查和甲胎蛋白水平与单纯肝细胞癌患者一致。结果表明,在台湾,肝细胞癌与另一种原发性恶性肿瘤同时发生或在其之后发生并不罕见。